Current Indications and New Applications of Intense Pulsed Light
نویسندگان
چکیده
منابع مشابه
Current indications and new applications of intense pulsed light.
Intense pulsed light (IPL) systems have evolved since they were introduced into medical practice 20 years ago. Pulsed light is noncoherent, noncollimated, polychromatic light energy emitted at different wavelengths that target specific chromophores. This selective targeting capability makes IPL a versatile therapy with many applications, from the treatment of pigmented or vascular lesions to ha...
متن کاملEfficacy of the intense pulsed light source on unwanted hairs
Background: The need for a rapid, non-invasive method for unwanted hair removal has led to the development of various light sources for this purpose. Objective: To evaluate the efficacy of Intense Pulsed Light Source (IPLS) on unwanted hairs. Patients and Methods: In this open, uncontrolled clinical trial, 77 different anatomical areas in 34 referred patients to “Novin Didegan Clinic” in Tehran...
متن کاملIntense Pulsed Light Therapy
Intense pulsed light (IPL) is one of the most effective nonablative approaches to treat skin photoaging. The broad range of wavelengths (500–1200 nm) emitted from IPL devices effectively target both melanin and hemoglobin in the skin. Numerous trials show the effectiveness and compatibility of IPL devices in a variety of skin conditions, especially in cosmetic indications such as hypertrichosis...
متن کاملUnconventional Use of Intense Pulsed Light
According to the literature, intense pulsed light (IPL) represents a versatile tool in the treatment of some dermatological conditions (i.e., pigmentation disorders, hair removal, and acne), due to its wide range of wavelengths. The authors herein report on 58 unconventional but effective uses of IPL in several cutaneous diseases, such as rosacea (10 cases), port-wine stain (PWS) (10 cases), di...
متن کامل[Intense pulsed light therapy for lupus pernio].
71 in 2008 in which Diaz et al 9 described a patient treated with adalimumab for rheumatoid arthritis whose lesions developed 2 months after the start of biologic treatment; and the third reported by Adenis-Lamarre et al 10 in 2009 in a patient with rheumatoid arthritis receiving adalimumab who developed skin lesions and was subsequently diagnosed with M chelonae infection. Our case differs fro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Actas Dermo-Sifiliográficas (English Edition)
سال: 2015
ISSN: 1578-2190
DOI: 10.1016/j.adengl.2015.04.001